Comparative safety of high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
Katarzyna Śladowska, Paweł Kawalec, Przemysław Holko, Oktawia Osiecka
Topics & Concepts
MedicineFingolimodCladribineOcrelizumabOfatumumabNatalizumabPlaceboAdverse effectInternal medicineAlemtuzumabCochrane LibraryRandomized controlled trialMultiple sclerosisRituximabDiseasePsychiatryPathologyAlternative medicineTransplantationLymphomaMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersPolyomavirus and related diseases